News Conference News WRAP IT: Novel Antibacterial ‘Envelope’ Reduces Rate of Infections From Implanted Cardiac Devices L.A. McKeown March 17, 2019
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
News Daily News FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD L.A. McKeown March 15, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News CRT 2019 Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven Yael L. Maxwell March 06, 2019
News Daily News AHA Details Accurate BP Measurement in Updated Scientific Statement Todd Neale March 04, 2019
News Daily News No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds L.A. McKeown March 01, 2019
News Daily News Long Bouts of Sedentary Time Linked to CVD Risk in Women Michael O'Riordan February 20, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Daily News AHA Warns of Stagnating CVD Gains, Barriers to Access, and Dismal Drug Pipeline Michael O'Riordan January 29, 2019
News Daily News Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines Todd Neale January 29, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2018 Caitlin E. Cox January 01, 2019
News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018
News Daily News Listen Up! Bacteria Commonly Found on Physician Stethoscopes Michael O'Riordan December 14, 2018
News Conference News WCC 2018 E-Cigarettes: Plausible Heart Risks Flagged in New Review Todd Neale December 10, 2018
News Conference News WCC 2018 True Resistant Hypertension Is Prevalent Worldwide Todd Neale December 07, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018